E-ISSN 3041-5594
 

Case Report
Online Published: 30 May 2025
 


Cerebral Toxoplasmosis: Effectiveness of Clindamycin Monotherapy in a Patient with Sulfonamide Allergy

Margareth Hildaria, Gabriel Alden Setiawan.


Abstract
Cerebral toxoplasmosis is a severe condition often associated with HIV-positive patients. It can present as a neurological emergency, making early detection and prompt treatment crucial to preventing further neurological damage. We present a 34-year-old man, previously undiagnosed with HIV, who presented with worsening headaches, photophobia, dizziness, nausea, vomiting, and slurred speech. Neurological examination revealed left-sided central facial (VII) and hypoglossal (XII) nerve palsies. Laboratory tests confirmed HIV infection and elevated anti-toxoplasma antibodies. Imaging showed multiple ring-enhancing lesions, vasogenic edema, and a midline shift. The patient was treated with clindamycin, folic acid, citicoline, paracetamol, and dexamethasone. Symptoms improved within three days, with resolution of headaches and improvement in speech. Follow-up CT scans after 6 weeks showed reduced edema and lesion size. Cerebral toxoplasmosis as the initial manifestation of HIV is rare but critical finding. Early diagnosis and treatment are essential for improved outcomes, highlighting the need to consider cerebral toxoplasmosis as a potential early sign of HIV infection. This case demonstrates that clindamycin alone can be an effective treatment for cerebral toxoplasmosis, particularly in resource-poor settings or for patients with sulfonamide allergies.

Key words: cerebral toxoplasmosis, vasogenic edema, clindamycin, monotherapy, sulfonamide allergy


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Margareth Hildaria
Articles by Gabriel Alden Setiawan
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Hildaria M, Setiawan GA. Cerebral Toxoplasmosis: Effectiveness of Clindamycin Monotherapy in a Patient with Sulfonamide Allergy. Case Rep Ser Med. 2025; 2(2): 32-35. doi:10.5455/CRSM.20250225031452


Web Style

Hildaria M, Setiawan GA. Cerebral Toxoplasmosis: Effectiveness of Clindamycin Monotherapy in a Patient with Sulfonamide Allergy. https://www.wisdomgale.com/crsm/?mno=302657846 [Access: June 08, 2025]. doi:10.5455/CRSM.20250225031452


AMA (American Medical Association) Style

Hildaria M, Setiawan GA. Cerebral Toxoplasmosis: Effectiveness of Clindamycin Monotherapy in a Patient with Sulfonamide Allergy. Case Rep Ser Med. 2025; 2(2): 32-35. doi:10.5455/CRSM.20250225031452



Vancouver/ICMJE Style

Hildaria M, Setiawan GA. Cerebral Toxoplasmosis: Effectiveness of Clindamycin Monotherapy in a Patient with Sulfonamide Allergy. Case Rep Ser Med. (2025), [cited June 08, 2025]; 2(2): 32-35. doi:10.5455/CRSM.20250225031452



Harvard Style

Hildaria, M. & Setiawan, . G. A. (2025) Cerebral Toxoplasmosis: Effectiveness of Clindamycin Monotherapy in a Patient with Sulfonamide Allergy. Case Rep Ser Med, 2 (2), 32-35. doi:10.5455/CRSM.20250225031452



Turabian Style

Hildaria, Margareth, and Gabriel Alden Setiawan. 2025. Cerebral Toxoplasmosis: Effectiveness of Clindamycin Monotherapy in a Patient with Sulfonamide Allergy. Case Reports and Series in Medicine, 2 (2), 32-35. doi:10.5455/CRSM.20250225031452



Chicago Style

Hildaria, Margareth, and Gabriel Alden Setiawan. "Cerebral Toxoplasmosis: Effectiveness of Clindamycin Monotherapy in a Patient with Sulfonamide Allergy." Case Reports and Series in Medicine 2 (2025), 32-35. doi:10.5455/CRSM.20250225031452



MLA (The Modern Language Association) Style

Hildaria, Margareth, and Gabriel Alden Setiawan. "Cerebral Toxoplasmosis: Effectiveness of Clindamycin Monotherapy in a Patient with Sulfonamide Allergy." Case Reports and Series in Medicine 2.2 (2025), 32-35. Print. doi:10.5455/CRSM.20250225031452



APA (American Psychological Association) Style

Hildaria, M. & Setiawan, . G. A. (2025) Cerebral Toxoplasmosis: Effectiveness of Clindamycin Monotherapy in a Patient with Sulfonamide Allergy. Case Reports and Series in Medicine, 2 (2), 32-35. doi:10.5455/CRSM.20250225031452